France Contraceptive Devices Market: Market Size & Forecast 2026

The French contraceptive devices market generated approximately $0.69 billion in 2025 and is forecast to grow at around 6.92% CAGR through 2030. France has one of the highest contraceptive prevalence rates in Europe, with the pill historically dominant but device-based methods gaining share. Reimbursement by the French national health insurance system (Assurance Maladie) covers most prescription contraceptive devices, supporting steady volume demand.

• •Market value of ~$0.69 billion in 2025 with ~6.92% CAGR through 2030
• •Prescription devices are largely reimbursed by Assurance Maladie
• •Devices are gaining share against oral contraceptives, particularly LARCs

Government subsidies covering contraception for women under 26 have expanded access to both short- and long-acting devices since 2022, boosting uptake of IUDs and implants. Demographic stability, growing single-person households, and delayed family formation are increasing lifetime contraceptive use. Additionally, rising awareness of sexually transmitted infections continues to sustain demand for barrier methods such as condoms.

• •Free contraception policy for women under 26 expanded in 2022
• •Delayed childbearing and smaller family sizes extend contraceptive use windows
• •Public health campaigns reinforce condom use and STI prevention

By product type, condoms represent the largest volume segment, while IUDs and implants lead in revenue terms because of higher unit prices and clinician-administered placement. Female devices collectively account for the majority of revenue, with male devices (primarily condoms) forming a smaller but stable share. Urban regions including Île-de-France, Auvergne-Rhône-Alpes, and Provence-Alpes-Côte d'Azur contribute the largest shares of national demand due to higher population density and healthcare infrastructure.

• •IUDs and implants lead revenue per unit; condoms dominate volume
• •Female devices generate the majority share of total market value
• •Île-de-France and major urban regions account for the largest demand concentrations

What are the recent trends and outlook?

Long-acting reversible contraceptives are expected to outpace short-term methods as more women and clinicians opt for lower-maintenance options. Digital health platforms, telemedicine consultations, and home-delivery pharmacy services are simplifying access to both prescription and non-prescription devices. Sustainability is also becoming a differentiator, with manufacturers introducing recyclable and plant-based condom lines to appeal to environmentally conscious consumers.

• •Shift toward LARCs is accelerating IUD and implant adoption
• •E-commerce and telemedicine are reshaping contraceptive distribution
• •Eco-friendly and plant-based condom products are emerging as a growth niche